Journey Medical (DERM) Net Cash Flow (2020 - 2026)
Journey Medical (DERM) posted Net Cash Flow of $3.1 million for Q1 2026, up 464.69% on a QoQ basis from -$858000.0 in Q4 2025, and up 309.02% year-over-year from $765000.0 in Q1 2025.
Journey Medical (DERM) Net Cash Flow (2020 - 2026) Analysis & Trends
Journey Medical's Net Cash Flow history runs 7 years deep, the most recent figure standing at $3.1 million for Q1 2026.
- Quarterly Net Cash Flow rose 309.02% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.1 million (down 48.81% YoY) and the FY2025 annual result came in at $3.8 million, up 153.06% from the prior year.
- Net Cash Flow was $3.1 million for Q1 2026 at Journey Medical, up from -$858000.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $12.8 million in Q4 2024 and bottomed at -$9.1 million in Q2 2023.
- A 5-year average of -$403647.1 and a median of -$858000.0 in 2025 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 420.81% in 2025, while the deepest fall reached 435.86% in 2025.
- Journey Medical's Net Cash Flow stood at -$2.9 million in 2022, then soared by 193.14% to $2.7 million in 2023, then surged by 377.47% to $12.8 million in 2024, then sank by 106.68% to -$858000.0 in 2025, then soared by 464.69% to $3.1 million in 2026.
- Business Quant data shows DERM's Net Cash Flow at $3.1 million in Q1 2026, -$858000.0 in Q4 2025, and $4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn | 3.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.13 Mn |
| Mar 31, 2026 | 3.13 Mn |
| Dec 31, 2025 | -858,000.00 |
| Dec 31, 2025 | -858,000.00 |
| Sep 30, 2025 | 4.66 Mn |
| Sep 30, 2025 | 4.66 Mn |
| Jun 30, 2025 | -777,000.00 |
| Jun 30, 2025 | -777,000.00 |
| Mar 31, 2025 | 765,000.00 |
| Mar 31, 2025 | 765,000.00 |
| Dec 31, 2024 | 12.84 Mn |
| Dec 31, 2024 | 12.84 Mn |
| Sep 30, 2024 | -1.45 Mn |
| Sep 30, 2024 | -1.45 Mn |
| Jun 30, 2024 | -145,000.00 |
| Jun 30, 2024 | -145,000.00 |
| Mar 31, 2024 | -3.38 Mn |
| Mar 31, 2024 | -3.38 Mn |
| Dec 31, 2023 | 2.69 Mn |
| Dec 31, 2023 | 2.69 Mn |